fMRI in CardiaC arrEst With Uncertain Prognosis
FACE-UP
The fMRI in CardiaC arrEst With Uncertain Prognosis (FACE-UP) Study
1 other identifier
observational
50
1 country
1
Brief Summary
The goal of this observational study is to determine whether specific advanced MRI measures are associated with functional outcomes in patients who are comatose after cardiac arrest. The main question\[s\] it aims to answer are: Aim 1: Determine if stimulus-based functional MRI (fMRI)-measured activations are independently associated with favorable neurological outcomes after cardiac arrest Aim 2: Determine if resting state functional MRI (rs-fMRI)-measured functional network connectivity is independently associated with favorable neurological outcomes after cardiac arrest. Aim 3: Determine if diffusion tensor imaging (DTI)-measured white matter integrity is associated with favorable neurological outcomes after cardiac arrest. Participants will undergo advanced MRI sequences at time of clinical MRI, and will be followed for 6 months post-arrest.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2024
CompletedStudy Start
First participant enrolled
May 16, 2024
CompletedFirst Posted
Study publicly available on registry
May 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
May 21, 2024
May 1, 2024
3 years
May 16, 2024
May 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Cerebral Performance Category Score 1-2
A standardized scale describing a patients overall level of independent function. Levels 1-2 reflect patients who are functionally independent in their iADLs.
6 months
Secondary Outcomes (1)
Cerebral Performance Category Score 1-3
2 weeks
Eligibility Criteria
Participants who have survive a cardiac arrest but remain unresponsive after completion of targeted temperature management (TTM). We will enroll a separate sample of 15 healthy controls to provide a normative range for our advanced MRI imaging measures.
You may qualify if:
- survive of an in or out of hospital cardiac arrest
You may not qualify if:
- Drug overdose
- Opinion of medical team patient unlikely to survive more than 24 hours (severe concurrent medical illness, dilated and unreactive pupils, etc..)
- Following verbal commands (MD or RN note) once TTM is complete and normothermia is achieved (Day 2 or 3; Day of admission is Hospital Day 0). If no TTM is administered, this can be assessed on Hospital Day 2.
- Following verbal commands (study team assessment) at time of MRI
- Family planning to WLST at time of enrollment
- Non English speaker (okay if English not primary language, as long as they can understand it)
- Permanent Contraindication to MRI (some kind of implanted metal)
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brigham and Women's Hospitallead
- American Heart Associationcollaborator
Study Sites (1)
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
May 16, 2024
First Posted
May 21, 2024
Study Start
May 16, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
May 21, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will share
Plan to post to openneuro.org